Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF UROLOGY
Volume 19, Issue 12, Pages 1050-1057
Publisher
Wiley
Online
2012-08-06
DOI
10.1111/j.1442-2042.2012.03115.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of the Systemic Inflammatory Response as a Biomarker in Immunotherapy for Renal Cell Cancer
- (2012) Sara Ramsey Molecular Diagnosis & Therapy
- IL-6 plays an essential role in neutrophilia under inflammation
- (2011) Misato Hashizume et al. CYTOKINE
- Combined Immunotherapy with Low-dose IL-2 Plus IFN- for Metastatic Renal Cell Carcinoma: Survival Benefit for Selected Patients with Lung Metastasis and Serum Sodium Level
- (2011) H. Akaza et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: role of IL-6 in overall survival
- (2010) Claudia E. Falkensammer et al. BJU INTERNATIONAL
- Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
- (2010) A N Jeppesen et al. BRITISH JOURNAL OF CANCER
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mild Hyponatremia Carries a Poor Prognosis in Community Subjects
- (2009) Ahmad Sajadieh et al. AMERICAN JOURNAL OF MEDICINE
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-6 Gene Knockout Influences Energy Balance Regulating Peptides in the Hypothalamic Paraventricular and Supraoptic Nuclei
- (2009) A. Benrick et al. JOURNAL OF NEUROENDOCRINOLOGY
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Clinical Outcome of Patients with Heart Failure and Preserved Left Ventricular Function
- (2008) Israel Gotsman et al. AMERICAN JOURNAL OF MEDICINE
- Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival
- (2008) N. S. Vasudev et al. CLINICAL CANCER RESEARCH
- The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey
- (2008) T.-I. Huo et al. DIGESTIVE AND LIVER DISEASE
- Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
- (2008) Kazutaka Saito et al. EUROPEAN UROLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Age-impaired fluid homeostasis depends on the balance of IL-6/IGF-I in the rat supraoptic nuclei
- (2008) K. Palin et al. NEUROBIOLOGY OF AGING
- Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
- (2008) W. Ray Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started